drugset / Trial / NCT04431960

Blackcurrants Modify Gut Microbiota and Reduce Osteoporosis and CVD Risk

NCT04431960 ↗

Phase 1 Completed 51 enrolled University of Connecticut
RandomizedParallel-groupQuadruple-blindPrevention

Summary

Aim to evaluate the effects of blackcurrant supplementation on changes in gut microbiome, bone mass, and CVD risk factors in adult women.

Timeline

Start
2021-07-20
Primary completion
2022-10-03
Completion
2022-10-03

Drugs

EvaluationDrugModalityDoseRoute
Comparator Blackcurrant (BC) extract Unknown 392 mg —
Comparator Blackcurrant (BC) extract Unknown 784 mg —